Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of AZD7009 for Conversion of Atrial Fibrillation
NCT00255281Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of azd7009 in Atrial fibrillation (AFib), sponsored by AstraZeneca. Started Sep 2005; status: completed.
02
Drugs
azd7009
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00255281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00255281.